Hims & Hers Health Inc.
HIMS | NYSE
$29.35
+$1.36 (+4.86%)
At close: Sep 21, 2026, 4:00 PM ET
$29.29
-$0.06 (-0.21%)
After-hours:
Sep 21, 2026, 7:58 PM ET
Company Profile
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Key Executives
| Name | Position |
|---|---|
| Andrew Dudum | Co-Founder, Chairman & Chief Executive Officer |
| Mike Chi | Chief Operating Officer |
| Mohamed ElShenawy | Chief Technology Officer |
| Oluyemi Okupe | Chief Financial Officer |
| Soleil Teubner Boughton | Chief Legal Officer & Corporate Secretary |
| Deborah Autor | Chief Policy Officer & Director |
| Irene A. Becklund | Chief Accounting Officer |
| Kathryn H. Beiser | Chief Communications Officer |
| Patrick Carroll | Global Chief Medical Officer |
| Sarah Stuart | Senior Vice President of People |
| William James Newby | Senior Director of Investor Relations |
Hims & Hers Health Inc.
| Country | United States |
| IPO Date | Sep 12, 2019 |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Employees | 2,442 |
| CEO | Andrew Dudum |
Contact Details
2269 Chestnut Street San Francisco,
California 94123 United States
Stock Details
| Ticker Symbol | HIMS |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001773751 |
| CUSIP Number | 433000106 |
| ISIN Number | US4330001060 |
| SIC Code | 8011 |
Recent News
- 14 hours ago / newsfilecorp.comROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
- 15 hours ago / newsfilecorp.comKaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) to Contact the Firm Before the Securities Class Action Deadline on November 2, 2026
- 18 hours ago / prnewswire.comHims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- 18 hours ago / gurufocus.comHims & Hers Health (HIMS) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before November 2, 2026 Lead Plaintiff Deadline
- 20 hours ago / newsfilecorp.comHIMS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
- 20 hours ago / globenewswire.comKaplan Fox Alerts Hims & Hers Health, Inc. (NYSE: HIMS) Investors to a Securities Class Action Lawsuit – Contact the Firm Before Deadline on November 2, 2026 for Leadership Role
- 21 hours ago / zacks.comInvestors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
- 1 day ago / globenewswire.comHIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - November 2, 2026 Deadline
- 2 days ago / defenseworld.netHims & Hers Health (NYSE:HIMS) Insider Sells $173,734.96 in Stock
- 2 days ago / globenewswire.comHims & Hers Health, Inc. Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
Add to Watchlist
Select watchlists to add or remove HIMS